Evaluation of the effect of intranasal desmopressin spray on the complications of kidney biopsy in renal failure

Phase 3

• Conditions: Condition 1: Bleeding. Condition 2: Kidney biopsy. Condition 3: Acute kidney failure.; Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedure; Acute kidney failure, unspecified; L76.22; N17.9

• Registration Number: IRCT20201019049075N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients referred for renal biopsy.

Exclusion Criteria

Serum creatinine equal or more than 2 mg/dl
serum sodium less than 130 meq/liter
taking anti-platelets or anticoagulants
thrombocytopenia
history of kidney cancer
solitary kidney
small size kidneys
active urinary tract infection
abnormal prothrombin time
Patients who have received any kind of renal replacement therapy (hemodialysis or peritoneal dialysis) within the week before the biopsy
Blood pressure more than 160/90 mmHg

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of the patients who develop hematoma. Timepoint: 24 hours post biopsy. Method of measurement: Ultrasound.;The proportion of the patients who develop hematuria. Timepoint: 24 hours post biopsy. Method of measurement: Urinalysis.